Oil-in-oil-emulsions with enhanced substantivity for the treatment of chronic skin diseases.

The therapy of chronic skin diseases often requires several applications of creams or ointments per day. This is inconvenient to the patients and frequently leads to poor acceptance and compliance. We therefore developed oil-in-oil-emulsions that deliver the active pharmaceutical ingredient (API) to the skin over a prolonged period of time. In this study, we compare the permeation of the API from a conventional formulation to its permeation from an oil-in-oil-emulsion under infinite and finite dosing. Furthermore, we evaluate the substantivity of the formulations. Our results show that the permeation from oil-in-oil-emulsions is constant over a prolonged time and that the emulsions show significantly higher substantivity than conventional formulations. Because of that, the treatment intervals can be extended substantially and compliance can be increased.

In vitro studies on release and skin permeation of nonivamide from novel oil-in-oil-emulsions.

The purpose of this study was to develop oil-in-oil-emulsions that facilitate long-term treatment for chronic pruritus with capsaicinoids. To this end, oil-in-oil-emulsions, which comprised polydimethyl siloxanes, silicone surfactant and castor oil, were examined. We used nonivamide, a synthetic analogue of capsaicin as the active pharmaceutical ingredient. It was incorporated into castor oil that formed the dispersed phase of the emulsion. We evaluated the influence of formulation variables (nonivamide content, phase volume ratio and viscosity of the silicone oil) on the in vitro release and the permeation of nonivamide. Permeation was found to be controlled by the nonivamide concentration in the dispersed phase and the phase volume ratio. Oil-in-oil-emulsions were found to produce constant permeation rates over a period of 10h. They are thus superior to conventional semisolid formulations as application intervals may be extended.